Impede-PKD Investigational drug trial

The procurement process led by Sheffield Teaching Hospitals NHS Foundation Trust, located at the Royal Hallamshire Hospital, Sheffield, involves the trial and supply of investigational medicinal products for the IMPEDE-PKD study. The project, titled "STH21643 IMPEDE-PKD Investigational Medicinal Product (IMP) Tender," falls under the pharmacy services industry category. It requires the procurement and distribution of Metformin XR 500mg and a matching placebo to 35-40 NHS Trusts across the UK.

Key procurement stages include planning, tendering, and awarding, with the contract running until the end of October 2028. The open procedure was utilised, adhering to the EU directives, and the project has successfully awarded the contract to Sharp Clinical Services (UK) Ltd on 13th February 2025, amounting to £400,000 GBP. This tender presents substantial growth opportunities for businesses involved in pharmaceutical manufacturing, packaging, and logistics.

The demand for capable suppliers to deliver high-quality investigational products and distribution services to numerous NHS Trusts makes it ideal for companies with experience in clinical trial supplies. SME suppliers specialising in pharmacy services, especially those with a proven track record in managing trial drugs, are well-positioned to compete in this tender, enabling them to expand their market presence and contribute to significant clinical research initiatives. Additionally, maintaining compliance with GMP and GDP, and providing comprehensive supply chain solutions, are critical for successful participation in this procurement.